NCT06384482View on ClinicalTrials.gov

SNC115 Injections in Patients With Recurrent/Refractory Small Cell Lung Cancer and Lung Large Cell Neuroendocrine Carcinoma

PHASE1RecruitingINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

April 30, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

December 30, 2025

Conditions
Recurrent/Refractory Small Cell Lung Cancer Lung Large Cell Neuroendocrine Carcinoma
Interventions
DRUG

SNC115 injection

SNC115 Injection is DLL3 CART.

Trial Locations (1)

200030

RECRUITING

Shanghai Chest Hospital, Shanghai

All Listed Sponsors
collaborator

Shanghai Chest Hospital

OTHER

lead

Shanghai Simnova Biotechnology Co.,Ltd.

INDUSTRY